UK markets closed

Enzychem Lifesciences Corporation (183490.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
2,055.00+55.00 (+2.75%)
At close: 03:30PM KST
Currency in KRW

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 314.48%
S&P500 52-week change 322.38%
52-week high 32,120.00
52-week low 31,110.00
50-day moving average 31,784.40
200-day moving average 31,643.23

Share statistics

Avg vol (3-month) 3389.07k
Avg vol (10-day) 3558.55k
Shares outstanding 57.84M
Implied shares outstanding 6N/A
Float 874.57M
% held by insiders 112.97%
% held by institutions 14.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 26:1
Last split date 317 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -12.27%
Operating margin (ttm)-15.53%

Management effectiveness

Return on assets (ttm)-4.01%
Return on equity (ttm)-4.74%

Income statement

Revenue (ttm)76.04B
Revenue per share (ttm)895.32
Quarterly revenue growth (yoy)249.20%
Gross profit (ttm)N/A
EBITDA -11.22B
Net income avi to common (ttm)-9.33B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)137.35B
Total cash per share (mrq)1,614.64
Total debt (mrq)5.66B
Total debt/equity (mrq)2.91%
Current ratio (mrq)12.33
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-10.26B
Levered free cash flow (ttm)-13.65B